Načítá se...
Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study
BACKGROUND: Territorial differences in the access to innovative anticancer drugs have been reported from many countries. The objectives of this study were to evaluate access to innovative treatments for metastatic lung cancer in France, and to assess whether socioeconomic indicators were predictors...
Uloženo v:
Vydáno v: | BMC Cancer |
---|---|
Hlavní autoři: | , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
BioMed Central
2018
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6196460/ https://ncbi.nlm.nih.gov/pubmed/30348130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4958-5 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|